Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
UKV91nZu0GFZ9Y4e
Français